Search company, investor...
Novadaq Technologies company logo

Novadaq Technologies

novadaq.com

Founded Year

2000

Stage

Acq - P2P | Acquired

Valuation

$0000 

About Novadaq Technologies

Novadaq Technologies is a developer of fluorescence imaging technology that provides surgeons with visualization of blood flow in vessels and related tissue perfusion in cardiac, cardiovascular, gastrointestinal, plastic, microsurgical, and reconstructive procedures.

Headquarters Location

5090 Explorer Dr

Mississauga, Ontario, L4W 4X6,

Canada

905-629-3822

Missing: Novadaq Technologies's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Novadaq Technologies's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Novadaq Technologies

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Novadaq Technologies is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

3,088 items

Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)

D

Digital Health

13,118 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

Novadaq Technologies Patents

Novadaq Technologies has filed 1 patent.

The 3 most popular patent topics include:

  • Medical imaging
  • Spectroscopy
  • Microscopy
patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/3/2015

4/19/2022

Endoscopy, Geometrical optics, Spectroscopy, Optical devices, Microscopy

Grant

Application Date

3/3/2015

Grant Date

4/19/2022

Title

Related Topics

Endoscopy, Geometrical optics, Spectroscopy, Optical devices, Microscopy

Status

Grant

Latest Novadaq Technologies News

Novadaq Technologies Inc Medical Equipment Deals and Alliances Profile Report Updated 16102018 Prices from USD $250

Dec 31, 2018

Summary Novadaq Technologies Inc Novadaq is a medical imaging company. It develops, manufactures and markets realtime fluorescence imaging technology products. The company's SPY Imaging Technology products include SPY Elite open surgical imaging system, PinPoint endoscopic fluorescence imaging system, Luna fluorescence angiography and FireFly robotic imaging system. SPY imaging core technology provides anatomic and physiologic images during surgical procedures, enabling surgeons to capture, print, review and archive the flow of blood in vessels, microvessels and cojoined vessels; and blood perfusion in tissue and organs. Novadaq's products find application in the operating rooms and other clinical settings where open and minimally invasive and interventional surgeries are performed. It offers products to surgeons through direct sales force and alliances with other companies. Novadaq is headquartered in Mississauga, Ontario, Canada. Novadaq Technologies Inc Medical Equipment Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary inhouse Medical eTrack deals database, and primary and secondary research. Scope Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description A brief description of the company's operations. Key Employees A list of the key executives of the company. Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors A list of the key competitors of the company. Key Recent Developments A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News

Novadaq Technologies Frequently Asked Questions (FAQ)

  • When was Novadaq Technologies founded?

    Novadaq Technologies was founded in 2000.

  • Where is Novadaq Technologies's headquarters?

    Novadaq Technologies's headquarters is located at 5090 Explorer Dr, Mississauga.

  • What is Novadaq Technologies's latest funding round?

    Novadaq Technologies's latest funding round is Acq - P2P.

  • Who are the investors of Novadaq Technologies?

    Investors of Novadaq Technologies include Stryker, H.I.G. BioHealth Partners and BDC Healthcare Venture Fund.

  • Who are Novadaq Technologies's competitors?

    Competitors of Novadaq Technologies include Optovue, InPhenix, M2S, CardioInsight Technologies, Profound Medical and 15 more.

Compare Novadaq Technologies to Competitors

F
Forth Photonics

Forth Photonics is a medical device company that designs, develops, manufactures and markets imaging systems for the non-invasive, in-vivo detection of cancerous and pre-cancerous lesions. Forth Photonics aims to help medical practitioners to improve patient care by incorporating advanced biophotonics and optical molecular imaging technologies to assist in early detection, diagnosis and monitoring.

B
Body Surface Translations

Body Surface Translations is a biomedical device company focused on discovery and marketing of imaging technology that can be used to estimate the weight of an animal. The initial target markets will be agribusiness (swine and cattle) but opportunities in other aspects of agriculture and human health are envisioned as well.

G
GMP Companies

GMP Companies, Inc. ("GMP"), the parent company of LifeSync Corporation. GMP is a company and was formed in 1999. GMP's historical mission was to develop and commercialize pharmaceutical, medical device and diagnostic technologies. Today, LifeSync Corporation, formerly known as GMP Wireless Medicine, is the sole commercial business of GMP Companies, Inc. LifeSync Corporation is a medical device company committed to the development of products that improve clinical outcomes for patients through the use of LifeSync products and technologies.

K
Kjaya

Kjaya is a company that received a SBIR Phase I grant for a project entitled: Semi-Autonomous Adaptive Neural and Genetic Segmentation of Medical Images. Their Phase I project will implement a physician-assisted, real-time adaptive system for the segmentation of anatomical structures in 3D medical image data. Medical image segmentation seeks to change the representation of an anatomical structure, making it more easily analyzed. Because of the extreme variability of these structures in biological systems, current idiosyncratic manual methods currently in use are tedious, time consuming, and error prone. Image segmentation cannot in general be programmatically solved. The proposed system is a Neural Network (NN) based adaptation of the individual data using parallel Graphics Processing Units (GPUs) and coupled with a Genetic Algorithm (GA) based adaptation across GPU cores. The system will build a diagnostically useful segmentation of the anatomical feature within seconds from an area of interest outlined by a physician using a Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) scan. Fast growth in medical imaging overwhelms available diagnosticians. An intuitive and inexpensive system to quickly and accurately deliver diagnostic relevant segmentation of medical images offers tremendous commercial value. Currently, each scan requires approximately 50 minutes of manual preparation. The diagnosis and treatment of an estimated 20 percent of diseases benefit from medical imaging. Newer scanning technologies have increased in resolution, but such techniques have not made segmenting easier or faster. The proposed method will enable more diagnostics to be done with the quality controlled directly by physicians.

Smart Animal Logo
Smart Animal

Smart Animal is a medical devices company developing prototypes to enable patient-specific imaging and targeted therapy.

C
Capsulution NanoScience AG

Capsulution Nanoscience AG are developers of advanced drug delivery carriers, medical devices and diagnostic particles.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.